Neuralbase AI Ltd. Files S-1 for Potential Offering
Ticker: BMPA · Form: S-1 · Filed: Jan 31, 2025 · CIK: 1130781
Sentiment: neutral
Topics: S-1, IPO, AI, Company_Filing
TL;DR
Neuralbase AI (fka Viratech) filed S-1. IPO incoming?
AI Summary
Neuralbase AI Ltd. filed an S-1 form on January 31, 2025, indicating a potential public offering. The company, formerly known as Viratech Corp., is incorporated in Nevada and has a business address in Bogota, Colombia. The filing details various financial instruments and agreements, including Series A Preferred Stock and asset purchase agreements, with dates ranging from March 2023 to August 2024.
Why It Matters
This S-1 filing signals Neuralbase AI Ltd.'s intention to go public, which could provide significant capital for its AI ventures and impact the competitive landscape in the AI sector.
Risk Assessment
Risk Level: medium — As a newly public company with a history of name changes and complex financial instruments, Neuralbase AI presents inherent risks typical of an S-1 filing.
Key Numbers
- 480000000 — Filing Values (Potentially related to offering size or valuation)
- 2500000000 — Filing Values (Potentially related to offering size or valuation)
- 10000000 — Filing Values (Potentially related to offering size or valuation)
Key Players & Entities
- NEURALBASE AI LTD. (company) — Filer of the S-1
- Viratech Corp. (company) — Former company name
- 20250131 (date) — Filing date
- NV (jurisdiction) — State of incorporation
- BOGOTA (location) — Business address city
- us-gaap:SeriesAPreferredStockMember (financial_instrument) — Mentioned in agreements
FAQ
What is the primary business of Neuralbase AI Ltd.?
The filing lists the Standard Industrial Classification as SERVICES-MOTION PICTURE & VIDEO TAPE PRODUCTION [7812], but the company name suggests AI operations.
When was the company formerly known as Viratech Corp. renamed Neuralbase AI Ltd.?
The filing indicates a name change date of 20130123 for the transition from Viratech Corp.
What is the company's business address?
The business address is listed as CALLE 98 NO.19 A - 79 AP, 410 LOCALIDAD DE CHAPINERO, BOGOTA, F8, 00000.
What types of preferred stock are mentioned in the filing?
The filing mentions 'us-gaap:SeriesAPreferredStockMember' and 'vira:ClassAPreferredStockShareMember'.
What is the filing number for this S-1 submission?
The SEC file number is 333-284623.
Filing Stats: 4,338 words · 17 min read · ~14 pages · Grade level 14.6 · Accepted 2025-01-31 15:02:00
Key Financial Figures
- $0.0001 — 0 shares of our common stock, par value $0.0001 (" Common Stock ") at a fixed price of
- $0.01 — (" Common Stock ") at a fixed price of $0.01 per share for the duration of this offe
- $400,000 — pany are sold, the Company will receive $400,000 in net proceeds. Assuming 30,000,000 sh
- $300,000 — pany are sold, the Company will receive $300,000 in net proceeds. Assuming 20,000,000 sh
- $200,000 — pany are sold, the Company will receive $200,000 in net proceeds. Assuming 10,000,000 sh
- $100,000 — pany are sold, the Company will receive $100,000 in net proceeds. There is no minimum am
- $400,000 M — g Summary: Total Amount to be Raised: $400,000 Minimum Amount Needed for next 12 months
- $50,000 — We anticipate that we need a minimum of $50,000 dollars to continue operations for the
- $300,000.00 — ng key areas: 1. Product Development: $300,000.00 Continued development and refinement
- $75,000.00 M — sary software/hardware 2. Marketing: $75,000.00 Marketing campaigns (digital, social medi
- $25,000.00 M — ts 3. Operations and Infrastructure: $25,000.00 Milestones: Over the 12-month period, the
Filing Documents
- vira_s1.htm (S-1) — 1291KB
- vira_ex51.htm (EX-5.1) — 12KB
- vira_ex102.htm (EX-10.2) — 17KB
- vira_ex231.htm (EX-23.1) — 2KB
- vira_ex107.htm (EX-FILING FEES) — 31KB
- vira_ex51img2.jpg (GRAPHIC) — 3KB
- vira_ex51img1.jpg (GRAPHIC) — 9KB
- 0001477932-25-000605.txt ( ) — 3683KB
- vira-20240930.xsd (EX-101.SCH) — 31KB
- vira-20240930_lab.xml (EX-101.LAB) — 168KB
- vira-20240930_cal.xml (EX-101.CAL) — 34KB
- vira-20240930_pre.xml (EX-101.PRE) — 140KB
- vira-20240930_def.xml (EX-101.DEF) — 90KB
- vira_s1_htm.xml (XML) — 373KB
Risk Factors
Risk Factors 10 Special Note Regarding Forward-Looking Statements 19 Industry And Other Data 20
Use Of Proceeds
Use Of Proceeds 21 Dividend Policy 21
Management's Discussion And Analysis Of Financial Condition And Results Of Operations
Management's Discussion And Analysis Of Financial Condition And Results Of Operations 23
Business
Business 26 Management 43 Executive And Director Compensation 43 Certain Relationships And Related Party Transactions 44 Principal Stockholders 44
Description Of Capital Stock
Description Of Capital Stock 45 Shares Eligible For Future Sale 47 Material U.S. Federal Income Tax Consequences To Non-U.S. Holders Of Our Common Stock 48 Legal Matters 52 Experts 52 Where You Can Find More Information 52 Index To Financial Statements 53 The Company has not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of Common Stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares of our Common Stock. Our business, financial condition, results of operations and prospects may have changed since that date. For investors outside the United States : We have taken no actions that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of Common Stock and the distribution of this prospectus outside the United States. 1 Table of Contents PROSPECTUS SUMMARY This summary highlights certain information appearing elsewhere in this prospectus. Because it is only a summary, it does not contain all of the information that you should consider before investing in shares of our common stock and it is qualified in its entirety by, and should be read in conjunction with, the more detailed in